home
:
about uctvs
:
contact
:
uctv
:
u of ca
:
browse by:
campuses
|
conferences
|
hosts
|
seminars
|
speakers
|
subjects
Pathways for Treatments in Autism Spectrum Disorder
(
2/11/2015
)
75
minutes
Also available:
Video Podcast
Audio Podcast
YouTube
+ share
description:
Child psychiatrist Dr. Jeremy Veenstra-VanderWeele explores the two main approaches for developing autism medicines. The first and most common approach is to evaluate a treatment in the total group of people affected by ASD, usually with a small number excluded due to the presence of a known genetic syndrome. The second approach is almost the exact opposite, to study a medication for ASD-related symptoms in a defined genetic syndrome that confers substantial risk of ASD but comprises less than 2% of individuals with ASD. Transformative treatments, though possibly not "cures," seem most likely to emerge from the second approach, but in a small group of children. In contrast, if the first approach is successful, we can expect a treatment that benefits a larger group of children, but likely benefits them less.
more on this subject:
The MET Receptor Tyrosine Kinase and Autism Risk
FGF Signaling and Neocortical Patterning
Automatically Mapping the Language Learning Environment of Young Children with Autism: Implications for Assessment and Intervention
see all from Neuroscience and Neurobiology >